CIK: 1291219 - Address: C/o Halozyme Therapeutics, Inc., 11388 Sorrento Valley Road, San Diego, CA 92121
21 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret114-00-4-6-17-51-15
S%wins1005075757510079

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

4/14/21 16:19
4/14/21
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKelley Kenneth JCADS-22545.000-5-3180D
3/1/21 20:08
3/1/21
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKelley Kenneth JCADS-22745.340-5-3185D
2/1/21 18:56
2/1/21
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKelley Kenneth JCADS-24148.120-5-3190D
1/4/21 17:07
1/4/21
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKelley Kenneth JCADS-21542.910-5-3195D
12/7/20 18:05
12/7/20
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKelley Kenneth JCADS-1,43941.000-35-15200D
12/2/20 17:55
12/2/20
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKelley Kenneth JCADS-1,30341.000-32-12235D
11/27/20 17:43
11/25/20
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKelley Kenneth JCADS.m-81441.370-20-7267D
6/22/15 17:04
6/18/15
HALOHalozyme Therapeutics IncDEHealthBioPrdBiological Products, (No DiagKelley Kenneth JCADS-42021.0033-20-9198D23711014646371933-1-48-14-28-63
3/9/15 17:00
3/5/15
HALOHalozyme Therapeutics IncDEHealthBioPrdBiological Products, (No DiagKelley Kenneth JCADS-61315.3321-40-17195D178764761030004-53010-38
5/25/07 19:28
5/25/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagKelley Kenneth JCADS.d-23110.263-23-6015D42631528911140-1-202-13-20-26-51
5/22/07 16:24
5/18/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagKelley Kenneth JCADS-15810.554-15-5015D483282295122141-20-2-5-19-22-52
5/9/07 16:16
5/7/07
HTIHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagKelley Kenneth JCADS.d-13010.400-13-4515D
5/1/07 16:17
4/30/07
HTIHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagKelley Kenneth JCADS.d-25810.320-25-6315D
4/24/07 16:19
4/23/07
HTIHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagKelley Kenneth JCADS.d-2218.840-25-6315D
4/17/07 16:07
4/16/07
HTIHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagKelley Kenneth JCADS.d-2279.070-25-6315D
4/10/07 16:56
4/9/07
HTIHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagKelley Kenneth JCADS.d-2118.460-25-6315D
4/4/07 16:15
4/2/07
HTIHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagKelley Kenneth JCADS.d-2018.050-25-6315D
3/28/07 16:27
3/27/07
HTIHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagKelley Kenneth JCADS-48.380-1-315D
3/28/07 16:26
3/26/07
HTIHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagKelley Kenneth JCADS.dm-2058.370-25-6116D
3/21/07 16:21
3/19/07
HTIHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagKelley Kenneth JCADS.d-2188.700-25-6315D
3/16/07 16:50
3/14/07
HTIHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagKelley Kenneth JCADS.d-1997.960-25-6315D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact